RMP1-14: A Powerful Tool for Mouse PD-1 Research RMP1-14, a innovative antibody, represents an essential resource for investigating murine PD-1 expression. The distinct recognition characteristics permits investigators to reliably determine PD-1 role in different host reactions and supports a understanding of disease processes. … Read More


Serplulimab represents a exciting breakthrough in cancer treatment , acting as a novel PD-L1 blocker designed to target the interaction between PD-L1 and its receptor . This action facilitates the body's natural defenses to recognize tumour cells more efficiently . Early research studies have shown efficacy in various malignancies, implying a im… Read More